Spontaneous Spinal Subdural Hematoma Secondary to Hemophilia A and Zanubrutinib

Abstract

Spontaneous spinal subdural hematomas (SSH) are rare occurrences that can occur most commonly secondary to vascular malformations or coagulopathies. Only a small fraction of spontaneous SSHs are caused by acquired coagulation disorders such as leukemia, hemophilia, and thrombocytopenia. This case report describes a patient with a history of Guillain–Barré syndrome (GBS), hemophilia A, and mantle cell lymphoma, on zanubrutinib therapy, a Bruton tyrosine kinase inhibitor associated with a risk of spontaneous hemorrhage. This patient developed a spontaneous spinal subdural hematoma, most likely due to the zanubrutinib therapy and exacerbated due to hemophilia. Treatment was delayed due to the patient's history of GBS that confounded the clinical diagnosis. This case is the first report of a spontaneous SSH in a patient on zanubrutinib, highlighting the need for a high index of suspicion for CNS hemorrhage in patients on Bruton's tyrosine kinase (BTK) inhibitor therapy.

Keywords

hemophilia - zanubrutinib - spinal subdural hematoma - hemorrhage - mantle cell lymphoma

Publication History

Received: 17 November 2021

Accepted: 11 January 2022

Accepted Manuscript online:
03 February 2022

Article published online:
14 March 2022

• References

• 1 Domenicucci M, Ramieri A, Ciappetta P, Delfini R. Nontraumatic acute spinal subdural hematoma: report of five cases and review of the literature. J Neurosurg 1999; 91 (1, Suppl) 65-73
• 2 de Beer MH, Eysink Smeets MM, Koppen H. Spontaneous spinal subdural hematoma. Neurologist 2017; 22 (01) 34-39
• 3 Pereira BJ, de Almeida AN, Muio VM, de Oliveira JG, de Holanda CV, Fonseca NC. Predictors of outcome in nontraumatic spontaneous acute spinal subdural hematoma: case report and literature review. World Neurosurg 2016; 89: 574-577.e7
• 4 Rathi N, Rathi A. Haemophilia A presenting as spontaneous spinal epidural haematoma in a 3-month-old infant. BMJ Case Rep 2010; 2010: bcr0520102997
• 5 Nirupam N, Pemde H, Chandra J. Spinal epidural hematoma in a patient with hemophilia B presenting as acute abdomen. Indian J Hematol Blood Transfus 2014; 30 (Suppl. 01) 54-56
• 6 Ahn DK, Jung WS, Lee JI. Hemophilia A in a senior patient: a case report of spinal epidural hematoma as first presentation. Asian Spine J 2015; 9 (03) 452-455
• 7 Meena AK, Jayalakshmi S, Prasad VS, Murthy JM. Spinal epidural haematoma in a patient with haemophilia-B. Spinal Cord 1998; 36 (09) 658-660
• 8 Eyster ME, Gill FM, Blatt PM, Hilgartner MW, Ballard JO, Kinney TR. Central nervous system bleeding in hemophiliacs. Blood 1978; 51 (06) 1179-1188
• 9 Kiehna EN, Waldron PE, Jane JA. Conservative management of an acute spontaneous holocord epidural hemorrhage in a hemophiliac infant. J Neurosurg Pediatr 2010; 6 (01) 43-48
• 10 von Hundelshausen P, Siess W. Bleeding by Bruton tyrosine kinase-inhibitors: dependency on drug type and disease. Cancers (Basel) 2021; 13 (05) 1103
• 11 Senis YA, Mazharian A, Mori J. Src family kinases: at the forefront of platelet activation. Blood 2014; 124 (13) 2013-2024
• 12 Song Y, Zhou K, Zou D. et al. Treatment of patients with relapsed or refractory mantle-cell lymphoma with zanubrutinib, a selective inhibitor of Bruton's tyrosine kinase. Clin Cancer Res 2020; 26 (16) 4216-4224
• 13 Tam CS, Opat S, Simpson D. et al. Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma. Blood Adv 2021; 5 (12) 2577-2585
• 14 Wang J, Zhao A, Zhou H, Zhu J, Niu T. Risk of bleeding associated with ibrutinib in patients with B-cell malignancies: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol 2020; 11: 580622